Dmitry Abramov
Overview
Explore the profile of Dmitry Abramov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gatuz M, Abu-Fanne R, Abramov D, Mamas M, Roguin A, Kobo O
Int J Cardiol Heart Vasc
. 2025 Mar;
57:101637.
PMID: 40083916
Background: Pulmonary embolism (PE) is a critical condition with significant morbidity and mortality, particularly among patients with chronic inflammatory diseases (CID) such as rheumatoid arthritis and systemic lupus erythematosus that...
2.
Rashid M, Abramov D, Naseer M, Van Spall H, Ahmed F, Lawson C, et al.
Eur Heart J Open
. 2025 Mar;
5(2):oeaf013.
PMID: 40078653
Aims: Heart failure (HF) following acute myocardial infarction (AMI) is a global health concern, but data on risk factors associated with HF hospitalization post-AMI are limited. Methods And Results: We...
3.
4.
Minhas A, Gupta K, Michos E, Sauer A, Sperling L, Nambi V, et al.
Prev Med Rep
. 2025 Mar;
51:103003.
PMID: 40028000
Objective: Unhealthy lifestyle habits are associated with increased morbidity and mortality. This study aims to examine the county-level association of physical inactivity, insufficient sleep, and current smoking, three elements of...
5.
Waqas S, Sohail M, Saad M, Minhas A, Greene S, Fudim M, et al.
J Card Fail
. 2025 Feb;
PMID: 39993464
Background: Heart failure (HF) with mildly reduced or preserved ejection fraction (HFpEF) accounts for over half of cases of HF, with obesity playing a key role. Residual risk remains high...
6.
Shah S, Mushahid H, Salman A, Farhan S, Latif F, Siddiqi R, et al.
Drugs Aging
. 2025 Feb;
42(3):195-211.
PMID: 39987306
Background: Recent guidelines recommend the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors (SGLT2i) in patients suffering from cardiorenal diseases. However, the safety and efficacy of SGLT2i in older adults with...
7.
Kheiwa A, Baek I, Harris I, Minhas A, Abramov D
Int J Cardiol Congenit Heart Dis
. 2025 Feb;
19:100552.
PMID: 39926129
Background: There are limited data on the prevalence of heart failure (HF) due to congenital heart diseases (CHD). Methods: The Global Burden of Disease (GBD) dataset was used to analyze...
8.
Doolub G, Raichman A, Abramov D, Bang V, Parwani P, Karunanithi K, et al.
Expert Rev Cardiovasc Ther
. 2025 Feb;
23(1-2):35-43.
PMID: 39916300
Background: We present an analysis of cardiovascular-related deaths specific to hematological cancer patients in the United States from 1999 to 2020, examining trends in relation to age, gender, and type...
9.
Minhas A, Sperling L, Al-Kindi S, Abramov D
Am Heart J Plus
. 2025 Feb;
50:100499.
PMID: 39895921
Background: The multiple cause of death files available through the Center for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) present underlying and contributing causes of...
10.
Waqas S, Aamir J, Dani S, Abramov D, Virani S, Minhas A
Diabetes Res Clin Pract
. 2025 Jan;
221:112012.
PMID: 39870181
This study analyzes U.S. diabetes mortality trends from 1968 to 2019 using CDC WONDER data. It reveals fluctuating age-adjusted mortality rates (AAMRs), with a decline halted between 2010-2019. Males saw...